6118 — Austar Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- HK$399.81m
- HK$651.27m
- CNY1.50bn
- 26
- 77
- 57
- 56
Annual cashflow statement for Austar Lifesciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 41.5 | 319 | 86.5 | -34.4 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3.13 | -192 | 0.741 | 55.3 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -24.3 | -262 | -165 | -129 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 52.2 | -103 | -37.9 | -62.6 | — |
| Capital Expenditures | -26.5 | -101 | -117 | -69.2 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -33.3 | 166 | -35.8 | 14.8 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -59.8 | 65 | -153 | -54.5 | — |
| Financing Cash Flow Items | -2.79 | -4.4 | -5.19 | -23.5 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5.51 | 59.3 | 125 | 147 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -13.1 | 20.5 | -64.8 | 30.1 | — |